GL1X · GenesisL1 explorer

UniProt Q4VCS5

Amot-p130 phosphopeptide (pS175) (Q4VCS5)

Amot-p130 phosphopeptide (pS175) (UniProt Q4VCS5), EC 2.3.2.26: 36 experimental structures and 1 predicted model on GenesisL1, 7 ligands bound, 54 pockets. Binding sites, druggability and experiment against prediction (TM-score)…

UniProt
Q4VCS5
Protein
Amot-p130 phosphopeptide (pS175)
EC
2.3.2.26
Experimental structures
36
Predicted models
1
Ligands
7
Pockets
54 · 12 records with a druggable one

Structures

37 records of Q4VCS5 in the MolNFT archive: 36 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
6JJXCrystal Structure of KIBRA and Angiomotin complexx-ray diffractionD, C——
6JJXCrystal structure of kibra and angiomotin complexx-ray diffractionD, C——
7LP2Structure of Nedd4L WW3 domainx-ray diffractionB, D, FSO41 (best 0.65)
7LP2Structure of NEDD4L WW3 domainx-ray diffractionB, D, FSO41 (best 0.65)
7LP3Structure of Nedd4L WW3 domainx-ray diffractionB, DSO4—
7LP3Structure of NEDD4L WW3 domainx-ray diffractionB, DSO4—
7LP5Structure of Nedd4L WW3 domainsolution nmrA——
7LP5Structure of NEDD4L WW3 domainsolution nmrA——
7NMACrystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptidex-ray diffractionP—2 (best 0.49)
7NMACrystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptidex-ray diffractionP—2 (best 0.49)
7NMWCrystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 40x-ray diffractionP—2 (best 0.53)
7NMWCrystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 40x-ray diffractionP—2 (best 0.53)
7NMXCrystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 12x-ray diffractionP—2 (best 0.43)
7NMXCrystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 12x-ray diffractionP—2 (best 0.43)
7NN2Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 41x-ray diffractionPK8W2 (best 0.53)
7NN2Crystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 41x-ray diffractionPK8W2 (best 0.53)
7NNDCrystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 09x-ray diffractionPK7N2 (best 0.62)
7NNDCrystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 09x-ray diffractionPK7N2 (best 0.62)
7NNECrystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 22x-ray diffractionPK922 (best 0.57)
7NNECrystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 22x-ray diffractionPK922 (best 0.57)
7NP2Crystal structure of 14-3-3 sigma in complex with 20mer Amot-p130 peptidex-ray diffractionP—2 (best 0.42)
7NP2Crystal structure of 14-3-3 sigma in complex with 20MER amot-P130 peptidex-ray diffractionP—2 (best 0.42)
7NPBCrystal structure of 14-3-3 sigma in complex with 20mer Amot-p130 peptide and fragment 09x-ray diffractionPK7N2 (best 0.61)
7NPBCrystal structure of 14-3-3 sigma in complex with 20MER amot-P130 peptide and fragment 09x-ray diffractionPK7N2 (best 0.61)
7NPGCrystal structure of 14-3-3 sigma in complex with 20mer Amot-p130 peptide and fragment 22x-ray diffractionPK921 (best 0.47)
7NPGCrystal structure of 14-3-3 sigma in complex with 20MER amot-P130 peptide and fragment 22x-ray diffractionPK921 (best 0.47)
7OQGTernary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ136x-ray diffractionP0AW2 (best 0.47)
7OQGTernary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ136x-ray diffractionP0AW2 (best 0.47)
7OQJTernary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ162x-ray diffractionP09W2 (best 0.40)
7OQJTernary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ162x-ray diffractionP09W2 (best 0.40)
7OQSTernary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ177x-ray diffractionP0BS2 (best 0.50)
7OQSTernary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ177x-ray diffractionP0BS2 (best 0.50)
7OQUTernary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ180x-ray diffractionP—2 (best 0.45)
7OQUTernary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ180x-ray diffractionP—2 (best 0.45)
7OQWTernary complex of 14-3-3 sigma, Amot-p130 phosphopeptide, and WQ178x-ray diffractionP—1 (best 0.40)
7OQWTernary complex of 14-3-3 sigma, amot-P130 phosphopeptide, and WQ178x-ray diffractionP—1 (best 0.40)
Q4VCS5AlphaFold monomer V2.0 prediction for angiomotin (Q4VCS5)predictedA——

Ligands

  • K7N · 5-[1-(2-azanylethyl)imidazol-4-yl]-4-phenyl-thiophene-2-carboximidamide · in 4 records
  • K92 · 5-[3-(2-azanylethyl)imidazol-4-yl]-4-phenyl-thiophene-2-carboximidamide · in 4 records
  • SO4 · Sulfate ion · in 4 records
  • 09W · ~{N}-[(5-carbamimidoyl-3-phenyl-thiophen-2-yl)methyl]-2,3-dihydro-1-benzofuran-7-carboxamide · in 2 records
  • 0AW · ~{N}-[(5-carbamimidoyl-3-phenyl-thiophen-2-yl)methyl]-2,3-dihydro-1-benzofuran-5-carboxamide · in 2 records
  • 0BS · 2-(1,3-benzodioxol-5-yl)-~{N}-[(5-carbamimidoyl-3-phenyl-thiophen-2-yl)methyl]ethanamide · in 2 records
  • K8W · 7-(6-azanyl-5-methyl-pyridin-2-yl)-1-benzothiophene-2-carboximidamide · in 2 records

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.